Romanian Society of Pharmaceutical Sciences
 

« Back to Farmacia Journal 5/2012

ADJUSTMENTS OF THE BIORELEVANT DISSOLUTION TESTING IN CASE OF OXICAMS ORAL SOLID DOSAGE FORMS

ION-BOGDAN DUMITRESCU1, IOANA DUMITRA DRĂGOICEA2, DUMITRU LUPULEASA3, DOINA DRAGANESCU1, DRAGOŞ FLORIAN CIOLAN4, DALIA SIMONA MIRON1*, FLAVIAN ŞTEFAN RĂDULESCU5

Carol Davila University of Medicine and Pharmacy, Faculty of Pharmacy, 6 Traian Vuia street, 020956, Bucharest, Romania.
1 Department of Pharmaceutical Physics and Informatics,
2 Clinical Emergency Hospital, Department of Plastic and Reconstructive Microsurgery,
3 Department of Pharmaceutical Technology and Biopharmaceutics,
4 Department of Pharmaceutical Chemistry,
5 Department of Drug Industry and Pharmaceutical Biotechnologies.

Download Full Article PDF

The paper presents the results of in vitro dissolution testing for oral solid dosage forms containing three representative oxicams in blank or standard, fast and fed state simulated intestinal fluids (FaSSIF/FeSSIF). Non-compendial PeakTM vessel were used in combination with an adapted composition of biorelevant media (1:2 dilution with the corresponding aqueous buffer system). The results revealed a significant contribution of the improved stirring profile to the release process in FeSSIF, counterbalancing the decreased concentration of endogenous tensioactive compounds. The dissolution efficiency was comparable for the two blank media. The implemented changes in composition of the biorelevant media and experimental design leaded to comparable variability of data, but request further evaluation of the discriminatory character for internal, formulationcontrolled factors.